GT Biopharma, Inc. (GTBP)
0.7121
+0.05
(+7.89%)
USD |
NASDAQ |
Jan 15, 09:33
GT Biopharma EPS Diluted (Quarterly): -0.8268 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| SELLAS Life Sciences Group, Inc. | -0.0626 |
| Lyell Immunopharma, Inc. | -2.126 |
| Plus Therapeutics, Inc. | -0.0412 |
| Geron Corp. | -0.0276 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.114M |
| Total Expenses (Quarterly) | 3.114M |
| Enterprise Value | 4.400M |
| Earnings Yield | -476.8% |
| Normalized Earnings Yield | -522.48 |